Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tonini

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted CancersKevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Proceedings. Biological Sciences|May 12, 2021
Evolutionary trade-offs between male secondary sexual traits revealed by a phylogeny of the hyperdiverse tribe Eumaeini (Lepidoptera: Lycaenidae)Wendy A Valencia-Montoya, Tiago B Quental, João Filipe R Tonini, et al.
Nature Communications|September 29, 2021
Probabilistic tsunami forecasting for early warningJ Selva, S Lorito, M Volpe, et al.
Plos Biology|July 11, 2024
A phylogeny-informed characterisation of global tetrapod traits addresses data gaps and biasesMario R Moura, Karoline Ceron, Jhonny J M Guedes, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Research Square|October 3, 2025
Anthropocene Imperilment of Ancient Diversity and Evolutionary Potential in Terrestrial VertebratesR Alexander Pyron, Mario R Moura, Rauri C K Bowie, et al.
Cancer Discovery|April 19, 2026
TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted CancersKevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Proceedings. Biological Sciences|May 12, 2021
Evolutionary trade-offs between male secondary sexual traits revealed by a phylogeny of the hyperdiverse tribe Eumaeini (Lepidoptera: Lycaenidae)Wendy A Valencia-Montoya, Tiago B Quental, João Filipe R Tonini, et al.
Nature Communications|September 29, 2021
Probabilistic tsunami forecasting for early warningJ Selva, S Lorito, M Volpe, et al.
Plos Biology|July 11, 2024
A phylogeny-informed characterisation of global tetrapod traits addresses data gaps and biasesMario R Moura, Karoline Ceron, Jhonny J M Guedes, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Research Square|October 3, 2025
Anthropocene Imperilment of Ancient Diversity and Evolutionary Potential in Terrestrial VertebratesR Alexander Pyron, Mario R Moura, Rauri C K Bowie, et al.
Cancer Discovery|April 19, 2026
TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.
Pageof 4